UMIT is the dedicated product and commercial division of Umhlanga Molecular Imaging & Therapy: Centres of Excellence. The division was established to translate institutional expertise in molecular imaging and radiopharmaceutical practice into high-quality, standardised consumables and reagent solutions for broader market deployment.

Building on the operational and clinical insight of its parent organisation, UMIT develops and supplies modular radiolabelling kits, reagents, and workflow-ready consumables designed for use in controlled radiopharmacy and research environments. Each product is engineered to support reproducibility, safety, and efficiency while aligning with evolving regulatory expectations.

UMIT operates with a strong emphasis on quality governance, scalability, and long-term value creation. As a product division, it combines scientific depth with disciplined execution, enabling the organisation to respond to growing global demand for reliable radiopharmaceutical infrastructure solutions.